HMPV Alert: India Monitors China Outbreak with No Immediate Cause for ConcernThe Indian Health Ministry announced on Friday that it is closely monitoring the recent reports of a Human Metapneumovirus (HMPV) outbreak in China, assuring that there is no cause for alarm. Director General of Health Services (DGHS) Dr. Atul Goel stated, "There is nothing to be alarmed about the present situation."
on
January 4, 2025
Revolutionizing Healthcare Data: DPDP Rules to Empower Doctors and PatientsIndia is at the cusp of a healthcare data revolution with the Digital Personal Data Protection (DPDP) Act moving closer to implementation. After 16 months of anticipation, the Ministry of Electronics and Information Technology (MeitY) has received Home Ministry approval for the draft rules, marking a critical step toward safeguarding digital personal data.
on
January 3, 2025
Kolkata’s Spurious Drug Bust: A Cautionary Alert for Healthcare ProfessionalsIn a decisive move to protect patient safety, the Central Drugs Standard Control Organization (CDSCO), East Zone, and the Drugs Control Directorate, West Bengal, have jointly seized a large quantity of potentially spurious anti-cancer, anti-diabetic, and other medications from a wholesale premises in Kolkata. The confiscated drugs, estimated to be worth approximately ₹6.60 crore, were discovered during a raid at M/s Care and Cure For You.
on
January 2, 2025
Revolutionizing Tinnitus Care: IIT-Bombay’s Breakthrough InnovationIn a remarkable leap forward for auditory healthcare, researchers from the Indian Institute of Technology Bombay (IIT-B) have introduced an innovative and affordable portable device for diagnosing and managing tinnitus, a condition that affects over 740 million people globally, according to a 2022 JAMA Neurology study.
on
January 1, 2025
Antidepressants sale up by 64%: India’s Mood-Elevators Market SoarsIndia has witnessed a remarkable 64% jump in the sales of antidepressants and mood elevators between 2020 and November 2024, with a market value spiraling from ₹1,540 crore to ₹2,536 crore. Key players include Escitalopram and Clonazepam, which have recorded a 59.35% sales increase. Sertraline follows close behind with a 48.2% rise, reflecting the overall growth in mental health awareness and prescription practices.
on
December 31, 2024

Featured

FDA Approves Blujepa (Gepotidacin): First New Oral Antibiotic for uUTIs in Nearly 30 Years
Lorundrostat Shows Promise in Treating Uncontrolled Hypertension in Pivotal Trials
Kerala School Reports Viral Meningitis Cases, Health Authorities on High Alert
DCGI’s Renewed Mandate: Wiping Out Substandard Drugs, Supporting MSMEs, and Regulating Medical Devices
Delhi Sees Surge in H1N1 and Influenza B Cases

Participate in India’s healthcare revolution

Create ABHA & store all your medical records with Eka care (Govt of India ABDM approved PHR app)

Create ABHA ID

Popular topics

#

newfeature

#

Partnership

#

funding